Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 3 hours agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval
Zacks via Yahoo Finance· 13 hours agoThis effort is backed by a funding agreement with CEPI, which aims to make the vaccine available to...
New $1.2 bn plan to boost African vaccine production launched | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 5 days agoA new $1.2 billion programme to massively boost vaccine production in Africa was launched on...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
Los Angeles Times· 6 days agoNot only have its results become more sharply partisan, favoring Republican and conservative...
Will WHO’s new guidance spur hepatitis B immunisation?
Pharmaceutical Technology via Yahoo Finance· 4 days agoCurrent treatment options offer less than a 2 – 8% functional cure rate, research indicates, which...
Yolo County reports 2 measles cases, first since 2015. Both were in unvaccinated children
Merced Sun-Star via Yahoo News· 3 days agoMeasles can be prevented with two doses of a measles, mumps, rubella vaccine (MMR) or a measles,...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoThat compares to 55.6% for Keytruda alone. Earlier in the year, one analyst called results from the...
A study conducted by IDIAPJGol and ISGlobal recommends enhancing immunity against COVID-19 in cancer...
Hardwood Paroxysm· 4 days agoWork that has just been published in the journal Nature CommunicationsIt recommends administering...
Wayne State University experts warn of potential t | Newswise
Newswise· 24 hours agoDETROIT — Low vaccination rates continue to create significant threats to public health for diseases such as whooping cough (pertussis), measles and COVID-19. Michigan's vaccination rates for ...
Gilead's Twice-Yearly Shot to Prevent HIV Succeeds in Late-Stage Trial - Slashdot
Slashdot· 3 days agoAn anonymous reader shared this report from CNBC: Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday ...